Terms: = Lymphoma AND SFPQ, PSF, 6421, ENSG00000116560, P23246 AND Treatment
5 results:
1. Likely uptake of a future a lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study.
Broadbent R; Armitage CJ; Crosbie P; Radford J; Linton K
BMC Pulm Med; 2022 Apr; 22(1):165. PubMed ID: 35484621
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of
Weber M; Jentzen W; Hofferber R; Herrmann K; Fendler WP; Rischpler C; Umutlu L; Conti M; Costa PF; Sraieb M; Kersting D
BMC Cancer; 2021 Jan; 21(1):62. PubMed ID: 33446147
[TBL] [Abstract] [Full Text] [Related]
3. ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.
Elliott J; Bai Z; Hsieh SC; Kelly SE; Chen L; Skidmore B; Yousef S; Zheng C; Stewart DJ; Wells GA
PLoS One; 2020; 15(2):e0229179. PubMed ID: 32074131
[TBL] [Abstract] [Full Text] [Related]
4. Does PET Reconstruction Method Affect Deauville Score in lymphoma Patients?
Enilorac B; Lasnon C; Nganoa C; Fruchart C; Gac AC; Damaj G; Aide N
J Nucl Med; 2018 Jul; 59(7):1049-1055. PubMed ID: 29242403
[TBL] [Abstract] [Full Text] [Related]
5. Prolactin induces expression of FGF-2 and a novel FGF-responsive NonO/p54nrb-related mRNA in rat lymphoma cells.
Too CK; Knee R; Pinette AL; Li AW; Murphy PR
Mol Cell Endocrinol; 1998 Feb; 137(2):187-95. PubMed ID: 9605521
[TBL] [Abstract] [Full Text] [Related]
